Pembrolizumab vs best supportive care for second-line advanced hepatocellular carcinoma: Randomized, phase 3 KEYNOTE-240 study
Finn, R., Chan, S.L., Zhu, A.X., Knox, J., Cheng, A-L., Siegel, A., Bautista, O., Watson, P.A., Kudo, M.Volume:
27
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw371.105
Date:
October, 2016
Fichier:
PDF, 41 KB
english, 2016